| Literature DB >> 33426535 |
Zhichao Li1,2,3, Lei Yu1,2,3, Dong Chen1, Zhaoyue Meng1, Wei Chen1,2,3,4, Weiren Huang1,2,3,5,4.
Abstract
Human cancer tissue-derived organoids maintain the mutational spectrum and histological characteristics of their parental tumors and thus provide a platform for predicting patients' responses to anticancer drugs. Here, we provide a fully detailed, step-by-step protocol to derive lung adenocarcinoma organoids from primary tumor tissues. Organoid lines can be generated with a success rate of 80% using our protocol. For complete details on the use and execution of this protocol, please refer to Li et al. (2020).Entities:
Keywords: Cancer; Cell Biology; Organoids
Mesh:
Year: 2020 PMID: 33426535 PMCID: PMC7779824 DOI: 10.1016/j.xpro.2020.100239
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Figure 1Establishment of human lung adenocarcinoma organoid cultures
(A) Photo of minced tumor tissue.
(B) Images of tumor tissue before and after digestion with Digestion Medium I.
(C) Photo of Matrigel domes plated in a well of a 6-well culture plate.
(D) Representative bright-field images of LADC organoids after seeding. Scale bar, 100 μm.
Figure 2Passaging of LADC organoids
(A) Representative bright-field images of LADC organoids need passaging.
(B) Representative bright-field images of organoids after dissociation using the mechanical dissociation method. Scale bar, 100 μm.
Figure 3Processing of LADC organoids
(A) Photo of organoids embedded in 2% agarose in an embedding cassette.
(B) Photo of organoids embedded in wax.
(C) Bright-field images of microscope slides containing lung adenocarcinoma organoids. Scale bar, 100 μm.
Figure 4LADC organoids preserve the histopathological features of the original tumor tissues
Histological H&E (A) and immunofluorescence images (B) of LADC organoids and the corresponding parental tumor. Paired LADC organoids and tumor tissue were stained for TTF-1, Napsin A, p40, and CK5. Nuclei were stained with DAPI (blue). Scale bar, 50 μm.
Figure 5LADC organoid culture contaminated with normal lung organoids
Arrows indicate normal lung organoids in a LADC organoid culture. Scale bar, 100 μm.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| p40 (1:100) | Maixin Biotech ( | Cat#RAB-0666 |
| TTF1 (1:100) | Maixin Biotech | Cat#MAB-0677; Clone MX011 |
| Napsin A (1:100) | Maixin Biotech | Cat#MAB-0704; Clone MX015 |
| CK5 (1:100) | Thermo Fisher | Cat#RM-2106-S0; Clone EP1601Y |
| Donkey anti-rabbit IgG (H+L) highly cross-adsorbed secondary antibody, Alexa Fluor 488 (1:1,000) | Thermo Fisher | Cat#A21206; RRID: |
| Goat anti-mouse IgG (H+L) cross-adsorbed secondary antibody, Alexa Fluor 555 (1:1,000) | Thermo Fisher | Cat#A21422; RRID: |
| Human lung adenocarcinoma tissue from a male patient | Shenzhen Second People's Hospital, China | n/a |
| Advanced DMEM/F-12 | Gibco | Cat#12634-010 |
| Antibiotic-antimycotic (100×) contains 10,000 units/mL of penicillin, 10,000 μg/mL of streptomycin, and 25 μg/mL of Gibco amphotericin B | Gibco | Cat#15240-062 |
| GlutaMAX supplement | Gibco | Cat#35050-061 |
| HEPES | Gibco | Cat#15630-080 |
| B-27 supplement (50×), serum free | Gibco | Cat#17504-044 |
| N-Acetylcysteine | Sigma | Cat#A9165; CAS: 616-91-1 |
| Nicotinamide | Sigma | Cat#N0636; CAS: 98-92-0 |
| SB202190 | Sigma | Cat#S7076; CAS: 350228-36-3 (anhydrous) |
| A83-01 | Sigma | Cat#SML0788; CAS: 909910-43-6 |
| Recombinant human R-spondin 1 protein | R&D Systems | Cat#4645-RS-250 |
| Human Noggin | Peprotech | Cat#120-10C |
| Y-27632 dihydrochloride | Abmole Bioscience | Cat#M1817; CAS: 129830-38-2 |
| Recombinant human FGF-10 | Peprotech | Cat#100-26 |
| Recombinant human KGF (FGF-7) | Peprotech | Cat#100-19 |
| Recovery cell culture freezing medium | Gibco | Cat#12648010 |
| TrypLE Express | Gibco | Cat#12605010 |
| Collagenase, type II | Gibco | Cat#17101015 |
| DNase I | Roche | Cat#11284932001 |
| Fetal bovine serum | Gibco | Cat#10091148 |
| PBS | Gibco | Cat#10010023 |
| Matrigel growth factor reduced (GFR) basement membrane matrix | Corning | Cat#356231 |
| 70 μm cell strainer | Corning | Cat#352350 |
| Falcon 10 mL serological pipet | Corning | Cat#357551 |
| Costar 6-well clear TC-treated multiple well plates | Corning | Cat#3516 |
| 0.22 μm filter | Millipore | Cat#SLGV033RB |
| 50 mL centrifuge tube | Corning | Cat#CLS430829 |
| 15 mL centrifuge tube | Corning | Cat#CLS430791 |
| 1.5 mL centrifuge tube | Beyotime | Cat#FCT116 |
| Cryogenic vials | Corning | Cat#38053 |
| Agarose | Sigma-Aldrich | Cat#A9414 |
| Biopsy processing/embedding cassettes | Citotest Scientific | Cat#0103-1101-16 |
| Hematoxylin solution | Baso Diagnostics | Cat#BA-4041 |
| Eosin solution | Baso Diagnostics | Cat#BA-4099 |
| Antigen retrieval buffer (50× citrate-EDTA buffer) | Maixin Biotech | Cat#MVS-0098 |
Digestion medium I
| Reagent | Final concentration | Amount |
|---|---|---|
| AdDMEM/F12+++ | 1× | 4.85 mL |
| Collagenase type II (250 mg/mL) | 5 mg/mL | 100 μL |
| DNase I (10 mg/mL) | 100 μg/mL | 50 μL |
| Y-27632 dihydrochloride (100 mM) | 10 μM | 0.5 μL |
Organoid culture medium
| Reagent | Final concentration | Amount |
|---|---|---|
| AdDMEM/F12 | n/a | 46.79 mL |
| Antibiotic-antimycotic (100×) | 1× | 0.5 mL |
| GlutaMAX supplement (100×) | 1× | 0.5 mL |
| HEPES (100×) | 1× | 0.5 mL |
| B-27 supplement (50×) | 1× | 1 mL |
| R-Spondin 1 (100 μg/mL) | 500 ng/mL | 250 μL |
| Noggin (100 μg/mL) | 100 ng/mL | 50 μL |
| 0.2 mg/mL FGF-10 (0.2 mg/mL) | 20 ng/mL | 5 μL |
| FGF-7 (0.25 mg/mL) | 20 ng/mL | 4 μL |
| N-Acetylcysteine (500 mM) | 1.25 mM | 125 μL |
| Nicotinamide (2 M) | 10 mM | 250 μL |
| SB202190 monohydrochloride hydrate (30 mM) | 10 μM | 16.7 μL |
| A83-01 (25 mM) | 500 nM | 1 μL |
| Y-27632 dihydrochloride (100 mM) | 10 μM | 5 μL |
| Step | Reagent | Time |
|---|---|---|
| Dehydration | 70% ethanol | 1 h |
| 80% ethanol | 1 h | |
| 95% ethanol | 1 h | |
| 100 % ethanol | 45 min | |
| Clearing | 50% ethanol + 50% xylene | 30 min |
| 100% xylene | 15 min | |
| 100% xylene | 15 min | |
| Wax infiltration | 50% xylene + 50% wax | 1 h |
| 100% wax | 1 h | |
| 100% wax | 1 h |
| Step | Reagent | Time |
|---|---|---|
| Deparaffinization | 100% xylene | 5 min |
| 100% xylene | 5 min | |
| Rehydration | 100% ethanol | 3 min |
| 100% ethanol | 3 min | |
| 95% ethanol | 3 min | |
| 80% ethanol | 1 min | |
| water | 5 min | |
| Hematoxylin staining | hematoxylin | 1 min |
| water | 3 min | |
| Differentiation | 0.5% hydrochloric acid in 70% ethanol | 10 s |
| water | 5 min | |
| Eosin staining | 95% ethanol | 10 s |
| eosin | 45 s | |
| Dehydration | 95% ethanol | 10 s |
| 95% ethanol | 10 s | |
| 100% ethanol | 1 min | |
| 100% ethanol | 1 min | |
| Clearing | 100% xylene | 1 min |
| 100% xylene | 1 min |